Biotest Aktiengesellschaft
FSX:BIO3.DE
27.1 (EUR) • At close September 16, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Biotest Aktiengesellschaft |
Symbool | BIO3.DE |
Munteenheid | EUR |
Prijs | 27.1 |
Beurswaarde | 1,396,125,659 |
Dividendpercentage | 0.14% |
52-weken bereik | 22.8 - 33.2 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Michael Ramroth |
Website | https://www.biotest.com |
An error occurred while fetching data.
Over Biotest Aktiengesellschaft
Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)